MannKind (MNKD) Reports Q1 Loss of $0.25/Share

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/5/2026

1. HUBS
2. EXPE
3. ARM
4. FIS
5. BROS
6. QCOM
7. DDOG
8. EW
9. ZG
10. W

Go back to MannKind (MNKD) Reports Q1 Loss of $0.25/Share

MannKind Corporation Reports 2018 First Quarter Financial Results

May 9, 2018 4:01 PM EDT

Q1 2018 Afrezza Net Revenue was $3.4 million; +184% vs. Q1 2017 (+234% under the 2017 revenue recognition model)Q1 2018 Net Cash Used in Operating Activities was $21.7 millionSTAT study results accepted for presentation at American Diabetes Associations 78th scientific sessionsInitiated Phase 1 clinical trial of Treprostinil Technosphere                         

WESTLAKE VILLAGE, Calif., May 09, 2018 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ: MNKD) today reported financial results for the first quarter ended March 31, 2018.

We started 2018 with solid growth of 184% in quarterly Afrezza sales year-over-year, which reflects our progression as a... More